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Abstract
The precursor (PRLH, P81277) for PrRP generates 31 and 20-amino-acid versions. QRFP43 (named after a
pyroglutamylated arginine-phenylalanine-amide peptide) is a 43 amino acid peptide derived from QRFP
(P83859) and is also known as P518 or 26RFa. RFRP is an RF amide-related peptide [29] derived from a
FMRFamide-related peptide precursor (NPVF, Q9HCQ7), which is cleaved to generate neuropeptide SF,
neuropeptide RFRP-1, neuropeptide RFRP-2 and neuropeptide RFRP-3 (neuropeptide NPVF).
Contents
This is a citation summary for Prolactin-releasing peptide receptor in the Guide to Pharmacology database
(GtoPdb). It exists purely as an adjunct to the database to facilitate the recognition of citations to and from the
database by citation analyzers. Readers will almost certainly want to visit the relevant sections of the database
which are given here under database links.
GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a
reference work which is most usefully represented as an on-line database. As in any publication this work
should be appropriately cited, and the papers it cites should also be recognized. This document provides a
citation for the relevant parts of the database, and also provides a reference list for the research cited by those
parts.
Please note that the database version for the citations given in GtoPdb are to the most recent preceding version
in which the family or its subfamilies and targets were substantially changed. The links below are to the current
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